Atlas Trials

ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder

Clinical trial NCT07169162 · WITHDRAWN

Trial details

NCT number
NCT07169162
Sponsor
Aytu BioPharma, Inc.
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2019-05-01
Primary completion
2025-09-05
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.